Hygeia, a Greek-listed diagnostic & therapeutic center, said its consolidated revenue amounted to 167.4 million euros in the January-September period, up 1.2 pct compared with the same period last year.
Nine-month EBITDA recorded a significant increase by 47.1 pct, amounting to 21.6 million euros. The company noted that the consolidated results for the interim periods of 2016 and 2015 have been negatively affected by the unilateral Greek government decisions for cutbacks when invoicing hospitalization fees and diagnostic tests for individuals insured with national insurer EOPYY (rebate and claw-back). These decisions are pursuant to Article 100 of Law 4172/2013 (Government Gazette Vol. A 167), were implemented retroactively as of 01/01/2013 and will continue to be in force until 31/12/2018, the company said.